Effectiveness Trial of Thermal Jacket
Testing the Role of Thermal Jacket in Attaining and Maintaining Euthermia Among Preterm and LBW Neonates in Clinical Setting of Bangladesh
1 other identifier
interventional
300
1 country
3
Brief Summary
Globally, over 15 million neonates are born preterm each year. They account for approximately 30% of global neonatal deaths and 19% of total neonatal deaths in Bangladesh. They usually die because they cannot maintain normal temperature due to their weight, immature skin and underdeveloped thermal regulatory capacity of the brain. Maintaining continuous Kangaroo Mother Care (KMC) for at least 16-20 hours/day, is sometimes not feasible for mothers or caregivers. In addition, we also have the challenge of keeping preterm or low birthweight (LBW) neonates warm during transportation. The scientists at icddr,b, Johns Hopkins University, and George Mason University developed the thermal jacket for keeping preterm or LBW neonate warm. We have already completed the laboratory trial on mannquins and clinical safety trial among preterm or LBW neonates. Now, we propose to build on our previous work by systematically testing the effectiveness trial of the 'thermal jacket' among preterm or LBW neonates at clinical settings. Hypothesis: Thermal jacket can increase the rate of euthermia among the preterm or LBW neonates in the selected health facilities in Bangladesh. Objectives: The aim of this study is to test whether the thermal jacket can attain and maintain euthermia of preterm or LBW neonates in clinical settings of Bangladesh.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Mar 2024
Shorter than P25 for phase_2
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 19, 2024
CompletedFirst Posted
Study publicly available on registry
February 26, 2024
CompletedStudy Start
First participant enrolled
March 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 22, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedMarch 7, 2024
March 1, 2024
10 months
February 19, 2024
March 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Body temperature of preterm or low birthweight neonates maintain the euthermic range.
The primary outcome of this phase is attainment and maintenance of euthermia, defined as i. Having reached to 36.5⁰ C for hypothermic neonates at any point of a single event, ii. Maintaining euthermia throughout the event and iii. Having risen the temperature up to the euthermic range within 1 hour if at any point neonate goes below euthermic range. The endpoint of each event will be ascertained for every neonate during the pre-phase and intervention-phase in the same manner regardless of whether the thermal jacket is used.
6 hours per event
Study Arms (2)
Thermal Jacket
EXPERIMENTALAs a intervention, the enrolled preterm or low birthweight neonates gets the thermal jacket as well as Kangaroo Mother Care for thermal care.
Kangaroo Mother Care
ACTIVE COMPARATORAs a control, the enrolled preterm or low birthweight neonates gets the conventional Kangaroo Mother Care only.
Interventions
In the intervention group, the enrolled preterm or low birthweight eligible neonates gets the intervention Thermal Jacket as well as Kangaroo Mother Care.
Skin-to-Skin care, provided by primary caregiver.
Eligibility Criteria
You may qualify if:
- KMC eligible neonates
- Heart rate 100-160 per minute
- Capillary Refill Time ≤ 3 sec
- Respiratory rate 30-59 per minute
- Breaths comfortable
- Pink in room air
You may not qualify if:
- In nasogastric tube
- In oxygen therapy
- In intravenous fluid
- Sign of respiratory distress
- Prolonged or frequent apnea
- Major surgical problem
- Gross congenital anomaly
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Lakshmipur District Hospital
Lakshmīpur, Chattogram, 3700, Bangladesh
Kushtia 250 Bedded General Hospital
Kushtia, Khulna Division, 7000, Bangladesh
Jamalpur 250 Beded General Hospital
Jamālpur, Mymensingh, 2000, Bangladesh
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anisuddin Ahmed, MS
International Centre for Diarrhoeal Disease Research, Bangladesh
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 19, 2024
First Posted
February 26, 2024
Study Start
March 1, 2024
Primary Completion
December 22, 2024
Study Completion
December 31, 2024
Last Updated
March 7, 2024
Record last verified: 2024-03